Table 3

Mortality and Post-Operative Outcomes for Matched Controls and Severe CHD Patients

Controls
(n = 417)
Severe (n = 417)
PatientsPatientsOdds Ratio (95% CI)p ValueRisk Difference (95% CI)
30-day mortality3 (0.7)24 (5.7)8.43 (2.52 to 28.21)<0.0010.050 (0.027 to 0.074)
Overall mortality5 (1.2)34 (8.1)7.32 (2.83 to 18.90)<0.0010.070 (0.041 to 0.098)
Cardiac arrest0 (0.0)13 (3.1)<0.001
Reintubation7 (1.7)21 (5.0)3.11 (1.31 to 7.39)0.0050.034 (0.009 to 0.058)
Infection18 (4.3)27 (6.5)1.54 (0.83 to 2.83)0.110.016 (−0.009 to 0.052)
Renal failure0 (0.0)4 (1.0)0.06
Neurological failure3 (0.7)4 (1.0)1.34 (0.30 to 6.01)0.500.002 (−0.010 to 0.015)
Thromboembolic complications1 (0.2)1 (0.2)1.00 (0.06 to 16.04)0.75−0.000 (−0.007 to 0.007)
30-day reoperation29 (7.0)32 (7.7)1.11 (0.66 to 1.87)0.400.007 (−0.028 to 0.043)
30-day readmission38 (9.1)41 (9.8)1.09 (0.68 to 1.73)0.410.007 (−0.033 to 0.047)

Values are n (%) unless otherwise indicated. p values in bold are Bonferroni-adjusted p ≤ 0.005 used to identify statistically significant differences.

ARD = absolute risk difference; CHD = congenital heart disease; CI = confidence interval.

  • Includes respiratory, urinary tract, and surgical site infections.